DMP-728 free base | CAS# 153345-74-5 | GPIIbDIIa antagonist

MedKoo Cat#: 413864 | Name: DMP-728 free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DMP-728 free base is a highly potent and selective GPIIbDIIa antagonist

Chemical Structure

DMP-728 free base

CAS#153345-74-5

Theoretical Analysis

MedKoo Cat#: 413864

Name: DMP-728 free base

CAS#: 153345-74-5

Chemical Formula: C25H36N8O7

Exact Mass: 560.2707

Molecular Weight: 560.61

Elemental Analysis: C, 53.56; H, 6.47; N, 19.99; O, 19.98

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

DMP-728 free base; XL118; XL 118; XL-118

IUPAC/Chemical Name

2-((5S,11S,14R)-14-ethyl-11-(3-guanidinopropyl)-12-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaaza-1(1,3)-benzenacyclohexadecaphane-5-yl)acetic acid

InChi Key

JWRYVLUXFOYZCH-SQNIBIBYSA-N

InChi Code

InChI=1S/C25H36N8O7/c1-3-16-24(40)33(2)18(8-5-9-28-25(26)27)23(39)30-13-19(34)31-17(11-20(35)36)22(38)29-12-14-6-4-7-15(10-14)21(37)32-16/h4,6-7,10,16-18H,3,5,8-9,11-13H2,1-2H3,(H,29,38)(H,30,39)(H,31,34)(H,32,37)(H,35,36)(H4,26,27,28)/t16-,17+,18+/m1/s1

SMILES Code

CC[C@H]1NC(c2cc(CNC([C@@H](NC(CNC([C@@H](N(C1=O)C)CCCNC(N)=N)=O)=O)CC(O)=O)=O)ccc2)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 560.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Mousa SA, DeGrado WF, Mu DX, Kapil RP, Lucchesi BR, Reilly TM. Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist. Circulation. 1996 Feb 1;93(3):537-43. doi: 10.1161/01.cir.93.3.537. PMID: 8565173. 2: Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK, et al. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation. 1994 Jan;89(1):3-12. doi: 10.1161/01.cir.89.1.3. PMID: 8281661. 3: Reilly TM, Mousa SA, Racanelli AL, Thoolen MJ, Flint SK, Bozarth JM, Mu DX, Walton HL. A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dog. Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2195-9. doi: 10.1161/01.atv.15.12.2195. PMID: 7489242. 4: Mousa SA, Flint S, Lorelli W, Hassell S, Bozarth J, De Grado W, Reilly TM. Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs. Thromb Res. 1994 Oct 15;76(2):109-19. doi: 10.1016/0049-3848(94)90182-1. PMID: 7863463. 5: Rote WE, Davis JH, Mousa SA, Reilly TM, Lucchesi BR. Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis. J Cardiovasc Pharmacol. 1994 Apr;23(4):681-9. doi: 10.1097/00005344-199404000-00025. PMID: 7516023. 6: Huang J, Rebello SS, Faul JD, Lucchesi BR. Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition. Pharmacology. 1999 May;58(5):252-64. doi: 10.1159/000028288. PMID: 10087466. 7: Saitoh H, Aungst BJ. Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonist. Pharm Res. 1997 Aug;14(8):1026-9. doi: 10.1023/a:1012149227756. PMID: 9279884. 8: Michaelis W, Turlapaty P, Gray J, Fiske WD, Faulkner E, Kornhauser D, Mousa SA. Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjects. Clin Pharmacol Ther. 1998 Mar;63(3):384-92. doi: 10.1016/S0009-9236(98)90170-9. PMID: 9542482. 9: Wu ST, Stampfli HF, Banks CM, Emm TA, Kapil RP, Padovani PK, Lee WM Jr, Huang SM. Determination of DMP 728, a IIb/IIIa receptor antagonist, in rat and dog plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Biomed Appl. 1994 Jul 1;657(1):254-60. doi: 10.1016/0378-4347(94)80097-9. PMID: 7952079. 10: Aungst BJ, Saitoh H. Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist. Pharm Res. 1996 Jan;13(1):114-9. doi: 10.1023/a:1016093704095. PMID: 8668658.